Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction

The American Journal of Cardiology
James D FlahertyDavid P Faxon

Abstract

Patients who have had a myocardial infarction (MI) are at high risk for developing left ventricular dysfunction (LVD), which predisposes them to heart failure and is associated with an increased mortality risk. Early coronary revascularization, either with percutaneous coronary intervention or coronary artery bypass graft surgery, plays an important role in the preservation and restoration of left ventricular function after MI. This article discusses the effects of primary and nonemergent percutaneous coronary revascularization procedures on survival, left ventricular function, and the occurrence of complications, such as recurrent MI and stroke, compared with the effects of thrombolytic therapy. In addition, this article describes rescue revascularization procedures for patients who failed thrombolysis and those presenting relatively late or with negative electrocardiographic findings. Advanced interventional techniques, such as percutaneous ventricular assist devices and bioabsorbable stents, are very promising and may potentially help improve the outcomes of post-MI patients with LVD; however, the use of these techniques requires further validation.

References

Nov 5, 1999·The New England Journal of Medicine·F ZijlstraH Suryapranata
Nov 21, 2000·Lancet·D HasdaiD R Holmes
Feb 15, 2001·JAMA : the Journal of the American Medical Association·J S HochmanUNKNOWN SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock
Sep 21, 2001·The American Journal of Cardiology·D RottUNKNOWN Working Group on Intensive Cardiac Care, Israel Heart Society
Aug 19, 2003·European Journal of Heart Failure·Eric J VelazquezUNKNOWN VALIANT Investigators
Jan 28, 2004·Circulation·Philippe Gabriel StegUNKNOWN Global Registry of Acute Coronary Events Investigators
Sep 1, 2004·Journal of the American College of Cardiology·Ioannis IakovouAntonio Colombo
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Jun 13, 2006·The American Journal of Cardiology·Taral N PatelStephen G Ellis
Oct 3, 2006·Journal of the American College of Cardiology·Anthony A BavryArman T Askari
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Ulf StenestrandUNKNOWN RIKS-HIA Registry
Nov 15, 2006·European Heart Journal·Nick Clappers, Freek W A Verheugt
Nov 16, 2006·The New England Journal of Medicine·Judith S HochmanUNKNOWN Occluded Artery Trial Investigators
Dec 7, 2006·JAMA : the Journal of the American Medical Association·Eric L EisensteinRobert M Califf
Feb 14, 2007·The New England Journal of Medicine·Gregg W StoneMartin B Leon
May 10, 2007·JAMA : the Journal of the American Medical Association·Paul ErneMatthias Pfisterer
Jun 5, 2007·Lancet·Raimund ErbelUNKNOWN PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators

❮ Previous
Next ❯

Citations

Oct 3, 2008·The American Journal of Cardiology·Matthew E HarinsteinMihai Gheorghiade
Oct 3, 2008·The American Journal of Cardiology·James D FlahertyCharles J Davidson
Jan 21, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Hang GaoLe-Xin Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.